- Pfizer gains rights to Medivation's Dimebon; deal terminated
- Pfizer acquires Rinat Neuroscience
- Pfizer licenses TransTech's TTP488 and TTP4000 RAGE modulators; later returns rights
- Lundbeck to sell Myriad's Flurizan in Europe;terminated
- TPG-Axon provides Eli Lilly with funds for Alzheimer's trials
- GSK gets Phase III anticonvulsant from Valeant
- Actelion partners orexin antagonist for insomnia with GSK
- GSK to option Cellzome's kinase inhibitors for inflammation
Ask The Analyst
Ask the Analyst is free for subscribers. Submit your question and one of our analysts will be in touch.
Your question has been successfully sent to the email address below and we will get back as soon as possible. firstname.lastname@example.org.
All fields are required.
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.